Benzinga | Feb 16, 2021 08:32AM EST

Anixa Biosciences Begins Animal Testing Of COVID-19 Therapeutic Candidates

SAN JOSE, Calif., Feb. 16, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that animal testing has commenced with two proprietary compounds that have shown potency in in vitro studies.